Verdemed Holdings Inc. (“Verdemed” or the “Company”) is pleased to announce the appointment of Mr. David Beatty as a member of its Board of Directors, and Mr. Alexandre Penha as Chief Financial Officer. Mr. Beatty and Mr. Penha have extensive Canadian capital markets experience, with solid track records of raising capital, building enterprises, managing IPOs and leading publicly traded companies.

Mr. Beatty has been a member of the Board of Directors at OMERS since 2013, serving on its Investment Committee and Human Resources Committee. Mr. Beatty brings 30 years of experience in investment banking, largely focused on equity financing and mergers and acquisitions. He is currently Managing Director, Industrial Alliance Securities. Mr. Beatty is the former Chief Executive Officer of Rio Novo Gold Inc. and Chairman of Rio Verde Minerals, and was a co-founder of Westwind Partners Inc., an investment bank that was acquired by Thomas Weisel Partners.

Mr. Beatty was a member of the TSX/OSC Mining Standards Task Force in 1997-1998, which drafted the National Instrument 43/101 regulations, and is also a past member of the IDA Corporate Finance Committee. He co-founded Yamana Gold Inc. and is a director of Guyana Goldfields. Mr. Beatty holds a B.Comm. (Queen’s) and an M.Phil., International Affairs (Cambridge), as well as an MBA (Harvard Business School).

Mr. Penha has more than 15 years of experience in Canadian capital markets, where he focused on junior companies, including roles in investment banking and equity research. He has also served as an executive officer of many TSX and TSX-V listed companies, where he played important roles in raising capital and arranging entry into public equity markets, as well as in corporate development and mergers and acquisitions strategies. His past positions include VP, Corporate Development and member of the Board of Directors of Australian-listed fertilizer company Fertoz Limited (ASX:FTZ). Mr. Penha has also been EVP, Corporate Development, director and chair of the Audit Committee of Search Minerals Inc. (TSXV:SMY); VP, Corporate Development of Aura Minerals Inc. (TSX:ORA); General Manager, Corporate Development of Rio Novo Gold (TSX:RN); and VP, Corporate Development of Rio Verde Minerals Development Corp. (TSX:RVD).

Mr. Penha also worked for more than seven years in corporate finance at several capital markets institutions based in Brazil. He holds an MBA (York University, Schulich School of Business), a B.Sc. economics (Rio de Janeiro State University) and a postgraduate degree in corporate finance (Getulio Vargas Foundation, Rio de Janeiro).

Verdemed welcomes David Beatty and Alexandre Penha to the company to join the rest of the senior leadership team and wishes them good luck and success in their new roles.

For more information, please visit

José Bacellar

President and CEO

About Verdemed

Verdemed is a Canadian medical cannabis company working to improve the health of millions of patients in Latin America. Based in Toronto, Verdemed’s multi-level and multi-market approach seeks to bridge the gap between the pharmaceutical and medical cannabis landscapes in Europe and North America and the clinical needs of patients and doctors in Latin America.

The Company’s international footprint provides strategic access to both effective natural cannabis therapies and innovative new products. Verdemed plans to offer a wide range of cannabinoid-based medications to Latin America in the coming years and expects these products to be fully approved by the regulatory agencies in the region, such as ANMAT, Anvisa, COFEPRIS, DIGEMID, Invima, and ISP.

With its Canadian-based products, Verdemed is uniquely positioned to address the steep regulatory hurdles in Latin America. The Company aspires to become the platform of choice for global innovators seeking to enter Latin Americawith new medical cannabis products.

Verdemed combines Canadian cannabis industry expertise with smart Latin American capital, general pharmaceutical business knowledge, superior regulatory affairs capabilities and top-tier medical experience. Verdemed is building the medical cannabis brand of choice for Latin America.

Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause actual results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statements, forward-looking information, or financial outlook that are incorporated by reference herein, except as required by applicable securities laws.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!


BevCanna Enterprises (CSE:BEV,OTCQQ:BVNNF,FWB:7BC) CEO Marcello Leone shared how the company is scaling up its products to forge partnerships and explore opportunities across Canada, the US and Western Europe. 

“Getting your standard processing license and being fully compliant at a federal level is critical in Canada, and we were successful in getting that done. Now we’re getting ready to launch our Keef line of beverages within the next 45 days,” Leone said. 

As a young company, Leone said BevCanna has only started, but it took a four-pronged approach to make sure that it is a revenue-generating company prepared for the opening of many jurisdictions for CBD-based products.

“We are blessed that we have a beautiful infrastructure of our own, a state-of-the-art bottling facility with a capacity of almost 200 million bottles per annum and a strong balance sheet of $55 million. We are in a strong position to scale and grow this company.”

BevCanna has received a Standard Processing License from Health Canada and is now fully authorized to begin production at its full-service, high-capacity beverage manufacturing facility. The company will begin production of its white-label products, number one US cannabis beverage brand Keef and its in-house beverages through licensed Canadian retailers, positioning the company to fully capitalize on the burgeoning Canadian cannabis-infused beverage sector.

Watch the full interview with CEO Marcello Leone above.

Keep reading... Show less

BioHarvest Sciences (CSE: BHSC) will be presenting at the Benzinga Cleantech Small Cap Conference taking place on April 22, 2021. We invite our shareholders and all interested parties to explore cleantech small cap investment opportunities through two days of networking, dealmaking and discovery.

Sign up to get a free spectator pass for the event:

Keep reading... Show less

Positive distributor feedback and strong consumer interest accelerating launch with distributors

Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today that its wholly-owned subsidiary Naturo Group has successfully completed its initial shipment of TRACE plant-based products to one of Japan’s largest beverage distributors.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or the “Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced an additional refreshment of its board of directors to further strengthen its leadership in the cannabis industry.

Keep reading... Show less